Previous 10 | Next 10 |
Gainers: Verona Pharma (NASDAQ: VRNA ) +181% . More news on: Verona Pharma plc, RumbleON, Inc., Checkpoint Therapeutics, Inc., Stocks on the move, , Read more ...
NEWTON, Mass., June 03, 2020 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorde...
Secoo (NASDAQ: SECO ) +85% as Qudian becomes largest shareholder. More news on: Secoo Holding Limited, Summit Wireless Technologies, Inc., RCM Technologies, Inc., Stocks on the move, , Read more ...
Westwater Resources (NASDAQ: WWR ) +144% on positive independent test results on ULTRA-PMG. More news on: Westwater Resources, Inc., Tenax Therapeutics, Inc., BioHiTech Global, Inc., Stocks on the move, , Read more ...
Digital Ally (NASDAQ: DGLY ) +81% as Body-camera, surveillance stocks surge pre-market after protests . More news on: Digital Ally, Inc., Allied Esports Entertainment Inc., CTI BioPharma Corp., Stocks on the move, , Read more ...
NEWTON, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, to...
Allena Pharmaceuticals ( ALNA ) Q1 results : Revenues: $0; Net loss: ($7.6M) (+33.3%); loss/share: ($0.31) (+43.6%); Quick Assets: $20.5M (-31.7%). More news on: Allena Pharmaceuticals, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read more ...
Allena Pharmaceuticals (NASDAQ: ALNA ): Q1 GAAP EPS of -$0.31 beats by $0.13 . More news on: Allena Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
-- Revised URIROX-2 Trial Design to Potentially Reduce Size and Cost of Trial -- -- Finalized Protocol and Selected Contract Research Organization for Phase 1 Clinical Trial of ALLN-346 -- -- Presenting Late-Breaking Abstract on Kidney Stone Risk and Association with Urinary...
Allena Pharmaceuticals (NASDAQ: ALNA ): Q4 GAAP EPS of -$0.47 beats by $0.06 . More news on: Allena Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Allena Pharmaceuticals Inc. Company Name:
ALNA Stock Symbol:
NASDAQ Market:
Allena Pharmaceuticals Inc. Website:
Buying Penny Stocks on July 29th? Here’s What You Need to Know If you’re looking for the best penny stocks to buy right now, there are hundreds of options to choose from. As a result, it all comes down to finding the best penny stocks that fit your trading strateg...
NEWTON, Mass., July 19, 2022 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) (“Allena” or the “Company”), a biopharmaceutical company deploying its novel oral biologic platform to discover, develop and commercialize first-in-class, oral enzyme the...
NEWTON, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorde...